Skip to main content
Erschienen in: CardioVascular and Interventional Radiology 7/2019

16.04.2019 | Clinical Investigation

Effects of Prostatic Artery Embolization on the Dynamic Component of Benign Prostate Hyperplasia as Assessed by Ultrasound Elastography: A Pilot Series

verfasst von: André Moreira de Assis, Airton Mota Moreira, Francisco Cesar Carnevale, Antonio Sergio Zafred Marcelino, Luciana Mendes de Oliveira Cerri, Alberto Azoubel Antunes, Miguel Srougi, Giovanni Guido Cerri

Erschienen in: CardioVascular and Interventional Radiology | Ausgabe 7/2019

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To determine the effects of prostatic artery embolization (PAE) on prostatic elasticity as assessed by Ultrasound Elastography (US-E), as well as to describe the feasibility and role of US-E as a novel tool in both pre- and post-PAE evaluation.

Materials and Methods

This is a prospective, single-center investigation that included eight patients undergoing PAE for treatment of lower urinary tract symptoms (LUTS) attributed to benign prostate hyperplasia (BPH). Baseline and 3-month follow-up evaluations were performed and included prostate-specific antigen (PSA), uroflowmetry, pelvic magnetic resonance imaging and clinical assessment using the International Prostate Symptom Score (IPSS) questionnaire and the IPSS-Quality of life (QoL) item. US-E with measurement of the prostatic Elastic Modulus (EM) was performed before PAE and at 1-month follow-up.

Results

After PAE, US-E showed a significant reduction of prostatic EM as assessed in kPa (33.14 vs. 47.24, − 29.8%, p = 0.002) and in m/s (3.75 vs. 4.63, − 19.0%, p < 0.001). Also, the transitional/peripheral zone ratio was significantly reduced by 45.36% (0.53 vs. 0.97, p < 0.05). All eight patients presented with significant LUTS improvement after PAE (p < 0.05 for IPSS, QoL, prostate volume, peak urinary flow rate and PSA).

Conclusions

Findings described in this study suggest that PAE significantly reduces prostatic EM, leading to a positive effect on BPH dynamic component related to prostatic elasticity. Also, it features US-E as an additional tool for pre- and post-PAE evaluation, describing a novel indication for this technology.
Literatur
1.
Zurück zum Zitat Antunes AA, Carnevale FC, da Motta-Leal-Filho JM, Yoshinaga EM, Cerri LM, Baroni RH, et al. Clinical, laboratorial and urodynamic findings of prostatic artery embolization for the treatment of urinary retention related to benign prostatic hyperplasia. A prospective singe-center pilot study. Cardiovasc Interv Radiol. 2013;36:978–86.CrossRef Antunes AA, Carnevale FC, da Motta-Leal-Filho JM, Yoshinaga EM, Cerri LM, Baroni RH, et al. Clinical, laboratorial and urodynamic findings of prostatic artery embolization for the treatment of urinary retention related to benign prostatic hyperplasia. A prospective singe-center pilot study. Cardiovasc Interv Radiol. 2013;36:978–86.CrossRef
2.
Zurück zum Zitat Bilhim T, Pisco JM, Rio Tinto H, Fernandes L, Pinheiro LC, Furtado A, et al. Prostatic arterial embolization to treat benign prostatic hyperplasia. J Vasc Interv Radiol. 2012;23:1403–15.CrossRefPubMed Bilhim T, Pisco JM, Rio Tinto H, Fernandes L, Pinheiro LC, Furtado A, et al. Prostatic arterial embolization to treat benign prostatic hyperplasia. J Vasc Interv Radiol. 2012;23:1403–15.CrossRefPubMed
3.
Zurück zum Zitat Bagla S, Martin CP, van Breda A, Sheridan MJ, Sterling KM, Papadouris D, et al. Early results from a United States trial of prostatic artery embolization in the treatment of benign prostatic hyperplasia. J Vasc Interv Radiol. 2014;25:47–52.CrossRefPubMed Bagla S, Martin CP, van Breda A, Sheridan MJ, Sterling KM, Papadouris D, et al. Early results from a United States trial of prostatic artery embolization in the treatment of benign prostatic hyperplasia. J Vasc Interv Radiol. 2014;25:47–52.CrossRefPubMed
4.
Zurück zum Zitat de Assis AM, Moreira AM, de Paula Rodrigues VC, Yoshinaga EM, Antunes AA, Harward SH, et al. Prostatic artery embolization for treatment of benign prostatic hyperplasia in patients with prostate > 90 g: a prospective single-center study. J Vasc Interv Radiol. 2015;26:87–93.CrossRefPubMed de Assis AM, Moreira AM, de Paula Rodrigues VC, Yoshinaga EM, Antunes AA, Harward SH, et al. Prostatic artery embolization for treatment of benign prostatic hyperplasia in patients with prostate > 90 g: a prospective single-center study. J Vasc Interv Radiol. 2015;26:87–93.CrossRefPubMed
5.
Zurück zum Zitat Gao YA, Huang Y, Zhang R, et al. prostatic arterial embolization versus transurethral resection of the prostate—a prospective, randomized, and controlled clinical trial. Radiology. 2014;270(3):920–8.CrossRefPubMed Gao YA, Huang Y, Zhang R, et al. prostatic arterial embolization versus transurethral resection of the prostate—a prospective, randomized, and controlled clinical trial. Radiology. 2014;270(3):920–8.CrossRefPubMed
6.
Zurück zum Zitat Carnevale FC, Iscaife A, Yoshinaga EM, et al. Transurethral resection of the Prostate (TURP) versus original and PErFecTED Prostate Artery Embolization (PAE) due to benign prostatic hyperplasia (BPH): preliminary results of a single center, prospective, urodynamic-controlled analysis. Cardiovasc Interv Radiol. 2016;39(1):44–52.CrossRef Carnevale FC, Iscaife A, Yoshinaga EM, et al. Transurethral resection of the Prostate (TURP) versus original and PErFecTED Prostate Artery Embolization (PAE) due to benign prostatic hyperplasia (BPH): preliminary results of a single center, prospective, urodynamic-controlled analysis. Cardiovasc Interv Radiol. 2016;39(1):44–52.CrossRef
7.
Zurück zum Zitat Ray AF, Powell J, Speakman MJ, et al. Efficacy and safety of Prostate Artery Embolization for benign prostatic hyperplasia: an observational study and propensity-matched comparison with transurethral resection of the prostate (the UK-ROPE study). BJU Int. 2018. https://doi.org/10.1111/bju.14249 [Epub ahead of print].CrossRefPubMed Ray AF, Powell J, Speakman MJ, et al. Efficacy and safety of Prostate Artery Embolization for benign prostatic hyperplasia: an observational study and propensity-matched comparison with transurethral resection of the prostate (the UK-ROPE study). BJU Int. 2018. https://​doi.​org/​10.​1111/​bju.​14249 [Epub ahead of print].CrossRefPubMed
8.
Zurück zum Zitat Pisco JM, Bilhim T, Pinheiro LC, et al. Medium- and long-term outcome of Prostate Artery Embolization for patients with benign prostatic hyperplasia: results in 630 patients. J Vasc Interv Radiol. 2016;27(8):1115–22.CrossRef Pisco JM, Bilhim T, Pinheiro LC, et al. Medium- and long-term outcome of Prostate Artery Embolization for patients with benign prostatic hyperplasia: results in 630 patients. J Vasc Interv Radiol. 2016;27(8):1115–22.CrossRef
9.
Zurück zum Zitat Carnevale FC, Moreira AM, Harward SH, et al. Recurrence of lower urinary tract symptoms following Prostate Artery Embolization for Benign Hyperplasia: single center experience comparing two techniques. Cardiovasc Interv Radiol. 2017;40(3):366–74.CrossRef Carnevale FC, Moreira AM, Harward SH, et al. Recurrence of lower urinary tract symptoms following Prostate Artery Embolization for Benign Hyperplasia: single center experience comparing two techniques. Cardiovasc Interv Radiol. 2017;40(3):366–74.CrossRef
10.
Zurück zum Zitat Moreira AM, de Assis AM, Carnevale FC, et al. A review of adverse events related to prostatic artery embolization for treatment of bladder outlet obstruction due to BPH. Cardiovasc Interv Radiol. 2017;40(10):1490–500.CrossRef Moreira AM, de Assis AM, Carnevale FC, et al. A review of adverse events related to prostatic artery embolization for treatment of bladder outlet obstruction due to BPH. Cardiovasc Interv Radiol. 2017;40(10):1490–500.CrossRef
11.
Zurück zum Zitat Wang XY, Zong HT, Zhang Y. Efficacy and safety of Prostate Artery Embolization on lower urinary tract symptoms related to benign prostatic hyperplasia: a systematic review and meta-analysis. Clin Interv Aging. 2016;11(11):1609–22.CrossRefPubMedPubMedCentral Wang XY, Zong HT, Zhang Y. Efficacy and safety of Prostate Artery Embolization on lower urinary tract symptoms related to benign prostatic hyperplasia: a systematic review and meta-analysis. Clin Interv Aging. 2016;11(11):1609–22.CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Kuang M, Vu A, Athreya S. A systematic review of prostatic artery embolization in the treatment of symptomatic benign prostatic hyperplasia. Cardiovasc Interv Radiol. 2017;40:655–63.CrossRef Kuang M, Vu A, Athreya S. A systematic review of prostatic artery embolization in the treatment of symptomatic benign prostatic hyperplasia. Cardiovasc Interv Radiol. 2017;40:655–63.CrossRef
13.
Zurück zum Zitat Uflacker A, Haskal ZJ, Bilhim T, et al. Meta-analysis of prostatic artery embolization for benign prostatic hyperplasia. J Vasc Interv Radiol. 2016;27(11):1686–97.CrossRef Uflacker A, Haskal ZJ, Bilhim T, et al. Meta-analysis of prostatic artery embolization for benign prostatic hyperplasia. J Vasc Interv Radiol. 2016;27(11):1686–97.CrossRef
14.
Zurück zum Zitat de Assis AM, Maciel MS, Moreira AM, de Paula Rodrigues VC, Antunes AA, Srougi M, et al. Prostate zonal volumetry as a predictor of clinical outcomes for Prostate Artery Embolization. Cardiovasc Interv Radiol. 2017;40:245–51.CrossRef de Assis AM, Maciel MS, Moreira AM, de Paula Rodrigues VC, Antunes AA, Srougi M, et al. Prostate zonal volumetry as a predictor of clinical outcomes for Prostate Artery Embolization. Cardiovasc Interv Radiol. 2017;40:245–51.CrossRef
15.
16.
17.
Zurück zum Zitat Zhai L, Polascik TJ, Foo WC, et al. Acoustic radiation force impulse imaging of human prostates: initial in vivo demonstration. Ultrasound Med Biol. 2012;38:50–61.CrossRefPubMed Zhai L, Polascik TJ, Foo WC, et al. Acoustic radiation force impulse imaging of human prostates: initial in vivo demonstration. Ultrasound Med Biol. 2012;38:50–61.CrossRefPubMed
18.
Zurück zum Zitat Zhang M, Fu S, Zhang Y, et al. Elastic modulus of the prostate: a new non-invasive feature to diagnose bladder outlet obstruction in patients with benign prostatic hyperplasia. Ultrasound Med Biol. 2014;40:1408–13.CrossRefPubMed Zhang M, Fu S, Zhang Y, et al. Elastic modulus of the prostate: a new non-invasive feature to diagnose bladder outlet obstruction in patients with benign prostatic hyperplasia. Ultrasound Med Biol. 2014;40:1408–13.CrossRefPubMed
19.
Zurück zum Zitat Alan B, Utangaç M, Goya C, Daggulli M. Role of Acoustic Force Impulse (ARFI) elastography in determination of severity of benign prostate hyperplasia. Med Sci Monit. 2016;22:4523–8.CrossRefPubMedPubMedCentral Alan B, Utangaç M, Goya C, Daggulli M. Role of Acoustic Force Impulse (ARFI) elastography in determination of severity of benign prostate hyperplasia. Med Sci Monit. 2016;22:4523–8.CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat Carnevale FC, Antunes AA. Prostatic artery embolization for enlarged prostates due to benign prostatic hyperplasia. How I do it. Cardiovasc Interv Radiol. 2014;37:1602–5.CrossRef Carnevale FC, Antunes AA. Prostatic artery embolization for enlarged prostates due to benign prostatic hyperplasia. How I do it. Cardiovasc Interv Radiol. 2014;37:1602–5.CrossRef
21.
Zurück zum Zitat Carnevale FC, Moreira AM. The “PErFecTED technique”: proximal embolization first, then embolize distal for benign prostatic hyperplasia. Cardiovasc Interv Radiol. 2014;37:1602–5.CrossRef Carnevale FC, Moreira AM. The “PErFecTED technique”: proximal embolization first, then embolize distal for benign prostatic hyperplasia. Cardiovasc Interv Radiol. 2014;37:1602–5.CrossRef
22.
Zurück zum Zitat Auffenberg GB, Helfand BT, McVary KT. Established medical therapy for benign prostatic hyperplasia. Urol Clin N Am. 2009;36:443–59.CrossRef Auffenberg GB, Helfand BT, McVary KT. Established medical therapy for benign prostatic hyperplasia. Urol Clin N Am. 2009;36:443–59.CrossRef
24.
Zurück zum Zitat Bosch JL, Bangma CH, Groeneveld FP, Bohnen AM. The long-term relationship between a real change in prostate volume and a significant change in lower urinary tract symptom severity in population-based men: the Krimpen study. Eur Urol. 2008;53:819–25.CrossRefPubMed Bosch JL, Bangma CH, Groeneveld FP, Bohnen AM. The long-term relationship between a real change in prostate volume and a significant change in lower urinary tract symptom severity in population-based men: the Krimpen study. Eur Urol. 2008;53:819–25.CrossRefPubMed
25.
Zurück zum Zitat Hattori T, Sugaya K. Mechanisms of action for α1-adrenoceptor blockers in storage symptoms with new insights into the micturition reflex. Life Sci. 2017;191:90–6.CrossRefPubMed Hattori T, Sugaya K. Mechanisms of action for α1-adrenoceptor blockers in storage symptoms with new insights into the micturition reflex. Life Sci. 2017;191:90–6.CrossRefPubMed
26.
Zurück zum Zitat Frenk NE, Baroni RH, Carnevale FC, et al. MRI findings after prostatic artery embolization for treatment of benign hyperplasia. AJR Am J Roentgenol. 2014;203:813–21.CrossRefPubMed Frenk NE, Baroni RH, Carnevale FC, et al. MRI findings after prostatic artery embolization for treatment of benign hyperplasia. AJR Am J Roentgenol. 2014;203:813–21.CrossRefPubMed
27.
Zurück zum Zitat Homma Y, Gotoh M, Yokoyama O, et al. Outline of JUA clinical guidelines for benign prostatic hyperplasia. Int J Urol. 2011;18:741–56.CrossRefPubMed Homma Y, Gotoh M, Yokoyama O, et al. Outline of JUA clinical guidelines for benign prostatic hyperplasia. Int J Urol. 2011;18:741–56.CrossRefPubMed
Metadaten
Titel
Effects of Prostatic Artery Embolization on the Dynamic Component of Benign Prostate Hyperplasia as Assessed by Ultrasound Elastography: A Pilot Series
verfasst von
André Moreira de Assis
Airton Mota Moreira
Francisco Cesar Carnevale
Antonio Sergio Zafred Marcelino
Luciana Mendes de Oliveira Cerri
Alberto Azoubel Antunes
Miguel Srougi
Giovanni Guido Cerri
Publikationsdatum
16.04.2019
Verlag
Springer US
Erschienen in
CardioVascular and Interventional Radiology / Ausgabe 7/2019
Print ISSN: 0174-1551
Elektronische ISSN: 1432-086X
DOI
https://doi.org/10.1007/s00270-019-02220-x

Weitere Artikel der Ausgabe 7/2019

CardioVascular and Interventional Radiology 7/2019 Zur Ausgabe

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.